| Market Cap | $33.0M | |
| Enterprise Value | — | |
| Revenue | $0 | −100.0% |
| Gross Profit | -$405,000 | — |
| EBITDA | -$58.1M | −214.5% |
| Net Income | -$60.8M | −189.7% |
| Diluted EPS | -$2.39 | −189.5% |
| Free Cash Flow | -$10.4M | — |
| DPS (FY2025) | $0.00derived |
| Trailing yield | 0.00% |
| Payout ratio | — |
| Growth streak | 0 yrs |
| 5y DPS growth | — |
| Fiscal year | DPS | YoY | Basis |
|---|---|---|---|
| FY20252025-06-30 | $0.00 | — | derived (paid ÷ diluted shares) |
| FY20242024-06-30 | $1.75 | — | reported |
| FY20232023-12-06 | — | — | reported |
| FY20232023-06-30 | $0.00 |
| Ratio | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Trend · 6y | vs own | vs sector |
|---|---|---|---|---|---|---|---|---|---|
| ▾Margins | |||||||||
| Gross Margin | 90.38% | 95.95% | 100.00% | — | — | — | — | — | |
| Operating Margin | −92.58% | −173.65% | −185.48% | −75.31% | 22.27% | — | — | — | |
| EBITDA Margin | −92.19% | −172.83% | −184.68% | −74.52% | 22.86% | — | — | — | |
| NOPAT Margin | — | — | −146.53% | −59.50% | 22.27% | — | — | — | |
| Net Margin | −169.96% | −117.83% | −132.69% | −65.55% | 27.23% | — | — | — | |
| FCF Margin | 120.20% | −93.90% | −120.95% | −107.59% | −77.31% | — | — | — | |
| OCF Margin | 123.43% | −91.86% | −119.78% | −107.51% | −77.30% | — | — | — | |
| Gross Profitability | 11.96% | 19.18% | 22.88% | — | — | — | — | — | |
| Capex Intensity | 3.22% | 2.03% | 1.18% | 0.07% | 0.01% | — | — | — | |
| ▸Returns on Capital · 3 ratios | |||||||||
| ▸DuPont factors (ROE drivers) · 4 ratios | |||||||||
| ▸Earnings quality · 6 ratios | |||||||||
| ▸Liquidity & coverage · 2 ratios | |||||||||
| ▸Leverage · 2 ratios | |||||||||
| ▸Working capital · 4 ratios | |||||||||
| ▸Capital allocation · 2 ratios | |||||||||
| ▸Per share · 6 ratios | |||||||||
| ▸Other · 1 ratios | |||||||||
The five drivers multiply to 27.5% vs reported ROE 61.7%. High ROE from margin and turnover is earned; from the equity multiplier it is borrowed.
| Line | 2020↗ | 2021↗ | 2022↗ | 2023↗ | 2024↗ | 2025↗ |
|---|---|---|---|---|---|---|
| Revenue | $27.8M | $34.8M | $40.7M | $48.8M | $65.3M | $0 |
| YoY % | +25.4% | +17.0% | +19.9% | +33.8% | -100.0% | |
| Cost of Revenue | $2.7M | $1.4M | $0 | — | — | — |
| YoY % | -47.3% | -100.0% | ||||
| R&D Expense | $34.1M | $69.4M | $85.6M | $52.5M | $16.6M | $3.9M |
| YoY % | +103.7% | +23.4% | -38.8% | -68.4% | -76.3% | |
| SG&A Expense | $16.7M | $24.4M | $30.5M | $33.1M | $23.3M | $13.5M |
| YoY % | +46.0% | +25.1% | +8.5% | -29.7% | -41.9% | |
| Total Operating Expenses | $53.5M | $95.2M | $116.2M | $85.6M | $50.8M | $17.5M |
| YoY % | +78.1% | +22.0% | -26.3% | -40.7% | -65.6% | |
| Operating Income | -$25.7M | -$60.4M | -$75.5M | -$36.8M | $14.5M | -$17.5M |
| Other Non-Operating Income | $0 | $486,000 | -$6,000 | -$22,000 | -$41,000 | -$16,000 |
| Impairment of Real Estate | — | — | — | $0 | $10.9M | $0 |
| YoY % | -100.0% | |||||
| Pretax Income | — | — | -$54.5M | -$31.8M | $17.8M | -$15.9M |
| Income Tax | $1,000 | $8,000 | $0 | $0 | $0 | $0 |
| YoY % | +700.0% | -100.0% | ||||
| Net Income (incl. NCI) | -$47.2M | -$41.3M | -$54.5M | -$31.8M | $17.8M | -$15.9M |
| Net Income | -$47.2M | -$41.0M | -$54.0M | -$32.0M | $17.8M | -$15.9M |
| Net Income to Common | -$47.2M | -$41.3M | -$54.5M | -$31.8M | — | — |
| EPS (Basic) | -$0.52 | -$0.37 | -$8.75 | -$4.78 | $2.67 | -$2.39 |
| EPS (Diluted) | -$0.52 | -$0.60 | -$9.99 | -$4.78 | $2.67 | -$2.39 |
| Weighted Avg Shares (Basic) | 91.1M | 112.5M | 6.2M | 6.7M | 6.7M | 6.7M |
| YoY % | +23.5% | -94.5% | +7.1% | 0.0% | 0.0% | |
| Weighted Avg Shares (Diluted) | 91.1M | 114.5M | 6.3M | 6.7M | 6.7M | 6.7M |
| YoY % | +25.7% | -94.5% | +6.5% | 0.0% | 0.0% | |
| Dividends Declared per Share | — | — | — | — | $2 | — |
The sector classification is SIC-derived, not official GICS. Statement lines are XBRL facts as filed with the company's home regulator (SEC EDGAR for US filers; ESEF/EDINET and other national regulators for foreign filers); ratios and other derived figures are computed from them. A blank cell means the tag was absent — never imputed.
| derived (paid ÷ diluted shares) |
| Ex-date | Amount | Pay date | Freq | Source |
|---|---|---|---|---|
| 2023-11-16 | $1.75 | 2023-12-06 | u | licensed |
